Find out more about Richard Fisher's experience
Richard Fisher's highlights
Richard Fisher's selected work
A Randomized Trial Of Radiation With Cetuximab Or Weekly Cisplatin In Low Risk Locoregiona..
Effect of p16 Status on the Quality-of-Life Experience During Chemoradiation for Locally A..
A Randomised Trial Of Preoperative Radiotherapy For Stage T3 Adenocarcinoma Of Rectum
The impact on health-related quality of life in the first 12 months: A randomised comparis..
Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma a..
Displaying the 2 most recent projects by Richard Fisher.
A Randomized Trial Of Radiation With Cetuximab Or Weekly Cisplatin In Low Risk Locoregionally Advanced Hpv-Associated Oropharyngeal Cancer
Cancers of the tonsil and base of tongue due to the human papilloma virus have a better prognosis than other head and neck cancers, but stan..
Displaying the 16 most recent scholarly works by Richard Fisher.
Randomized Trial of Systemic Therapy After Involved-Field Radiotherapy in Patients With Early-Stage Follicular Lymphoma: TROG 99.03
Michael MacManus, Richard Fisher, Daniel Roos, Peter O'Brien, Andrew Macann, Sidney Davis, Richard Tsang, David Christie, Bev McClure, David Joseph, Jayasingham Jayamohan, John F Seymour
Journal article | 2018 | Journal of Clinical Oncology
Effect of p16 Status on the Quality-of-Life Experience During Chemoradiation for Locally Advanced Oropharyngeal Cancer: A Substudy of Randomized Trial Trans-Tasman Radiation Oncology Group (TROG) 02.02 ( HeadSTART)
Jolie Ringash, Richard Fisher, Lester Peters, Andy Trotti, Brian O'Sullivan, June Corry, Lizbeth Kenny, Walter Van Den Bogaert, Chris Wratten, Danny Rischin
Journal article | 2017 | International Journal of Radiation Oncology*Biology*Physics
The impact on health-related quality of life in the first 12 months: A randomised comparison of preoperative short-course radiation versus long-course chemoradiation for T3 rectal cancer (Trans-Tasman Radiation Oncology Group Trial 01.04)
Sue-Anne McLachlan, Richard J Fisher, John Zalcberg, Michael Solomon, Bryan Burmeister, David Goldstein, Trevor Leong, Stephen P Ackland, Joseph McKendrick, Bev McClure, John Mackay, Samuel Y Ngan
Journal article | 2016 | European Journal of Cancer
Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial
Michael A Henderson, Bryan H Burmeister, Jill Ainslie, Richard Fisher, Juliana Di Iulio, B Mark Smithers, Angela Hong, Kerwin Shannon, Richard A Scolyer, Scott Carruthers, Brendon J Coventry, Scott Babington, Joao Duprat, Harald J Hoekstra, John F Thompson
Journal article | 2015 | The Lancet Oncology
A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy - Adjuvant Versus Early Salvage (RAVES) trial
Maria Pearse, Carol Fraser-Browne, Ian D Davis, Gillian M Duchesne, Richard Fisher, Mark Frydenberg, Annette Haworth, Chakiath Jose, David J Joseph, Tee S Lim, John Matthews, Jeremy Millar, Mark Sidhom, Nigel A Spry, Colin I Tang, Sandra Turner, Scott G Williams, Kirsty Wiltshire, Henry H Woo, Andrew Kneebone
Journal article | 2014 | BJU International
Absence of a Relationship between Tumor 18F-fluorodeoxyglucose Standardized Uptake Value and Survival in Patients Treated with Definitive Radiotherapy for Non-Small-Cell Lung Cancer
Ming-Yin Lin, Muzo Wu, Sinead Brennan, Marie-Pierre Campeau, David Sidney Binns, Michael MacManus, Benjamin Solomon, Rodney J Hicks, Richard John Fisher, David Lee Ball
Journal article | 2014 | Journal of Thoracic Oncology
Correlation of p16 status, hypoxic imaging using [18F]-misonidazole positron emission tomography and outcome in patients with loco-regionally advanced head and neck cancer
Mateya E Trinkaus, Rodney J Hicks, Richard J Young, Lester J Peters, Ben Solomon, Mathias Bressel, June Corry, Richard Fisher, David Binns, Grant A McArthur, Danny Rischin
Journal article | 2014 | Journal of Medical Imaging and Radiation Oncology
The complex relationship between lung tumor volume and survival in patients with non-small cell lung cancer treated by definitive radiotherapy: A prospective, observational prognostic factor study of the Trans-Tasman Radiation Oncology Group (TROG 99.05)
David L Ball, Richard J Fisher, Bryan H Burmeister, Michael G Poulsen, Peter H Graham, Michael G Penniment, Shalini K Vinod, Hedley E Krawitz, David J Joseph, Greg C Wheeler, Bev E McClure
Journal article | 2013 | Radiotherapy and Oncology
Randomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04
Samuel Y Ngan, Bryan Burmeister, Richard J Fisher, Michael Solomon, David Goldstein, David Joseph, Stephen P Ackland, David Schache, Bev McClure, Sue-Anne McLachlan, Joseph McKendrick, Trevor Leong, Cris Hartopeanu, John Zalcberg, John Mackay
Journal article | 2012 | Journal of Clinical Oncology
Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial
Bryan H Burmeister, Michael A Henderson, Jill Ainslie, Richard Fisher, Juliana Di Iulio, B Mark Smithers, Angela Hong, Kerwin Shannon, Richard A Scolyer, Scott Carruthers, Brendon J Coventry, Scott Babington, Joao Duprat, Harald J Hoekstra, John F Thompson
Journal article | 2012 | Lancet Oncology
Prognostic and Predictive Significance of Plasma HGF and IL-8 in a Phase III Trial of Chemoradiation with or without Tirapazamine in Locoregionally Advanced Head and Neck Cancer
Le Quynh-Thu, Richard Fisher, Kelly S Oliner, Richard J Young, Hongbin Cao, Christina Kong, Edward Graves, Rodney J Hicks, Grant A McArthur, Lester Peters, Brian O'Sullivan, Amato Giaccia, Danny Rischin
Journal article | 2012 | Clinical Cancer Research
Prognostic Significance of Plasma Osteopontin in Patients with Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Treated on TROG 02.02 Phase III Trial
Annette M Lim, Danny Rischin, Richard Fisher, Hongbin Cao, Kathleen Kwok, Daniel Truong, Grant A McArthur, Richard J Young, Amato Giaccia, Lester Peters, Quynh-Thu Le
Journal article | 2012 | Clinical Cancer Research
Relationship between Epidermal Growth Factor Receptor Status, p16(INK4A), and Outcome in Head and Neck Squamous Cell Carcinoma
Richard J Young, Danny Rischin, Richard Fisher, Grant A McArthur, Stephen B Fox, Lester J Peters, June Corry, Annette Lim, Kelly Waldeck, Benjamin Solomon
Journal article | 2011 | Cancer Epidemiology, Biomarkers & Prevention
N2-N3 neck nodal control without planned neck dissection for clinical/radiologic complete responders - Results of Trans Tasman Radiation Oncology Group study 98.02
June Corry, Lester Peters, Richard Fisher, Andrew Macann, Michael Jackson, Bev McClure, Danny Rischin
Journal article | 2008 | Head & Neck
Mathematics And Statistics